Publications Structure-based Design of Pyridone−Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition 30 June 2025 /images/2025/Aminal_eFT508-JMC_Cover_Story.pdf Previous article: Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor Prev Next article: Olgotrelvir, A Dual Inhibitor of SARS-CoV-2 Mpro and Cathepsin L, as a Standalone Antiviral Oral Intervention Candidate for COVID-19 Next
